Aarti Drugs (NSE:AARTIDRUGS) FFO


NSE:AARTIDRUGS Aarti Drugs Ltd NSE:AARTIDRUGS
73 GF Score
Price ₹386.60
GF Value ₹498.02
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Aarti Drugs FFO?

FFO (Funds from operations) only applies to REITs.

NSE:AARTIDRUGS
73GF Score
Aarti Drugs Ltd NSE:AARTIDRUGS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aarti Drugs (NSE:AARTIDRUGS) Overvalued in 2026?

Based on GuruFocus' analysis, Aarti Drugs stock appears to be undervalued. The current stock price of ₹386.60 is trading 22.4% below its estimated GF Value™ of ₹498.02. GuruFocus considers Aarti Drugs to be Modestly Undervalued.

Key valuation signals for NSE:AARTIDRUGS:

  • FFO:
  • GF Value™: ₹498.02 vs. price of ₹386.60 (22.4% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the NSE:AARTIDRUGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aarti Drugs Business Description

Other Exchanges 524348:India
Address Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
73GF Score

Get the complete analysis for NSE:AARTIDRUGS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹386.60
Price
₹498.02
GF Value